Spin-Off

Facing delisting, BioRestorative executes another reverse split. We dive into whether this financial maneuver can sustain it or just delays the inevitable.

Capstone retired 75% of its dilutive convertible notes, a major milestone. But with a low stock price and reliance on an equity line, is this a true pivot?

Interpace Biosciences is engineering its stock for a Nasdaq uplist, but is this financial maneuver a path to sustained growth or a classic warning sign?

From explorer to producer, PDI Gold's name change and share consolidation signal a bold new chapter. But can it navigate financial hurdles and regional risks?

MDB Capital celebrates a string of successful IPOs but reports a staggering $16.1M loss, putting its unique 'public venture' model under intense scrutiny.

MSG Sports posts record profits fueled by a Knicks NBA title, but the real story is the strategic gamble to split its empire, creating long-term risks.

Haoxi Health announces a second reverse split in three months, a move to save its Nasdaq listing that investors see as a red flag, despite its strategic AI push.

A routine dividend from Genuine Parts Company offers a rare look into the financial health of the vast, physical network that keeps our world moving.

MySize Inc. is consolidating its shares to stay on Nasdaq. We go beyond the press release to analyze if this financial maneuver is a path to stability or a warning sign.

As Johnson & Johnson prepares for a key investor conference, its strategy hinges on a potent mix of new drugs, robotic surgery, and a leaner focus.

Onfolio Holdings is betting on a 1-for-50 reverse split to save its Nasdaq listing. But is it a lifeline or a red flag for a company facing deeper issues?

Aeternum Health is no more. Reborn as a critical minerals supplier and led by a proven team, it's betting $4 million on a Nigerian mine to tackle US supply chain risk.

As ADI Global Distribution begins trading independently, we dive into the numbers behind the Resideo spin-off. What does it mean for investors and the industry?

Finnish conglomerate Aspo Plc is demerging into two listed firms, ESL Shipping and Telko Group, betting that strategic focus will unlock significant value.

The AI firm used a strategic maneuver to avoid delisting, but does its pivot to enterprise AI signal a true recovery or just a temporary market fix?

As ARKO Corp. preps its Q2 report, all eyes are on whether its recent strategic overhaul, including the IPO of its fuel arm, can deliver growth.

G3 Goldfields launches as a pure-play Guyana explorer, armed with C$45M and a veteran team aiming to replicate its multi-million-ounce discoveries.

G Mining Ventures acquires G2 Goldfields, creating a tier-one gold complex in Guyana and spinning off a new exploration firm. A masterclass in M&A.

Facing delisting pressure, gold miner Blue Gold is deploying a high-stakes playbook. But is its struggle a company-specific issue or a warning for all small-caps?

DBGI announced a massive program expansion, but a recent stock split, weak financials, and a fight against market anomalies paint a complex picture.